Tara Fernandez
Tara Fernandez is a Cell Biologist who commercializes new technology in the biotechnology industry. She reports on innovation and trends in the fields of regenerative medicine, cell therapies and nanotechnologies. Tara is involved in various science communication and public engagement initiatives to promote STEM in the community. Follow her on Twitter @DrTFern.
Posts by: Tara
What stroke patients can teach us about treating COVID-19
Regenerative medicines could have life-saving potential by dampening inflammation The COVID-19 pandemic is one of modern medicine’s greatest challenges. There have been 20 million (and counting) confirmed cases worldwide and, if predictions are right, the worst is yet to come in the absence of a preventative or therapeutic drug. There is, however, cause for optimism […]
Antibodies help create a safe passage for T cell troops to defeat solid tumours
Immunotherapies have been heralded as a revolutionary paradigm shift in how cancer is treated, thanks to the exceptional cancer-killing properties of checkpoint inhibitors and chimeric antigen receptor (CAR) T cells. Today, approved therapies Yescarta™ and Kymriah™, which use rewired T cells, have offered newfound hope for some patients with leukemia and lymphoma. In clinical trials, […]
Melanoma feels the STING with new RNA nanoparticle vaccine
RNA-based vaccines have been heralded as a new molecular weapon in the arsenal against cancer and infections. Five years ago, they were thrust into the spotlight following a $52 million investment by the Bill and Melinda Gates Foundation to CureVac, a biopharmaceutical company advancing RNA vaccines to the global health care stage. Today, over two […]
Comments